Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil

Journal of Acquired Immune Deficiency Syndromes

Volumn 51, Issue 5, 2009, Pages 624-630

  Pacheco, Antonio G ^a,b   Tuboi, Suely H ^b,c   May, Silvia B ^c   Moreira, Luiz F S ^c   Ramadas, Luciana ^c   Nunes, Estevão P ^c   Merçon, Mônica ^c   Faulhaber, José C ^c   Harrison, Lee H ^b   Schechter, Mauro ^c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

AIDS; Brazil; Causes of death; HIV

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAZIL; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW UP; HEPATITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURVIVAL RATE; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ALGORITHMS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAZIL; CAUSE OF DEATH; COHORT STUDIES; DEVELOPING COUNTRIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; TIME FACTORS; YOUNG ADULT;

EID: 68449098699     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181a4ecf5     Document Type: Article

References (33)

1. Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817-824.
2. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853-860.
3. Brito AM, Castilho EA, Szwarcwald CL. Regional patterns of the temporal evolution of the AIDS epidemic in Brazil following the introduction of antiretroviral therapy. Braz J Infect Dis. 2005;9:9-19.
4. Marins JR, Jamal LF, Chen SY, et al. Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS. 2003;17:1675-1682.
5. Crum NF, Riffenburgh RH, Wegner S, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr. 2006;41:194-200.
6. Sackoff JE, Hanna DB, Pfeiffer MR, et al. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006;145:397-406.
7. Smit C, Geskus R, Walker S, et al. Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion. AIDS. 2006;20:741-749.
8. Palella FJ Jr, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43:27-34.
9. Lewden C, May T, Rosenthal E, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalite 2000 and 2005" surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr. 2008;48:590-598.
10. Novoa AM, de Olalla PG, Clos R, et al. Increase in the non-HIV-related deaths among AIDS cases in the HAART era. Curr HIV Res. 2008;6:77-81.
11. Casau NC. Perspective on HIV infection and aging: emerging research on the horizon. Clin Infect Dis. 2005;41:855-863.
12. Friis-Moller N, Sabin CA, Weber R, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349:1993-2003.
13. d'Arminio A, Sabin CA, Phillips AN, et al. Cardio- and cerebrovascular events in HIV-infected persons. AIDS. 2004;18:1811-1817.
14. Friis-Moller N, Reiss P, Sabin CA, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N EnglJ Med. 2007;356:1723-1735.
15. El-Sadr WM, Lundgren JD, Neaton JD, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355:2283-2296.
16. Pacheco AG, Tuboi SH, Faulhaber JC, et al. Increase in non-AIDS related conditions as causes of death among HIV-infected individuals in the HAART era in Brazil. PLoS ONE. 2008;3:e1531.
17. Schechter M, Zajdenverg R, Machado LL, et al. Predicting CD4 counts in HIV-infected Brazilian individuals: a model based on the World Health Organization staging system. J Acquir Immune Defic Syndr. 1994;7:163-168.
18. Dabis F, Balestre E, Braitstein P, et al. Cohort profile: antiretroviral therapy in lower income countries (ART-LINC): international collaboration of treatment cohorts. Int J Epidemiol. 2005;34:979-986.
19. Pacheco AG, Saraceni V, Tuboi S, et al. Validation of a hierarchical deterministic record linkage algorithm using data from two different cohorts of HIV-infected individuals and mortality databases in Brazil. Am J Epidemiol. 2008;168:1326-1332.
20. CoDe. Coding causes of death in HIV Available at: www.cphiv.dk/CoDe. Accessed January 25, 2007; 2007.
21. CDC. From the Centers for Disease Control and prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA. 1993;269:460.
22. WHO. International Statistical Classification of Diseases and Health Related Problems ICD-10, Volume 2: Instruction Manual. 2nd ed. WHO; 2004.
23. Agresti A. Categorical Data Analysis. 2nd ed. New York, NY: Wiley-Interscience; 2002.
24. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol. 2005;162:975-982.
25. Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York, NY: Springer; 2000.
26. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26:2389-2430.
27. Gaynor JJ, Feuer EJ, Tan CC, et al. On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J Am Stat Assoc. 1993;88:400-409.
28. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
29. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141-1154.
30. Gray B. cmprsk: Subdistribution Analysis of Competing Risks. Version 2.2-0. [computer program]. 2006.
31. R Development Core Team. R: A language and Environment for Statistical Computing. Version 2.4.0. [computer program]. Vienna, Austria: R Foundation for Statistical Computing; 2006.
32. 3. J Acquir Immune Defic Syndr. 2007;44:179-187.
33. Monforte A, Abrams D, Pradier C, et al. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS. 2008;22:2143-2153.